Researchers at The University of Texas MD Anderson Cancer Center have confirmed a protein as an oncogene responsible for the most common and lethal form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). ...
Sep 4, 2019
0
1114
A powerful analytical tool, known as UTMOST, developed by Hongyu Zhao, Ph.D., the Ira V. Hiscock Professor of Biostatistics at the Yale School of Public Health, and colleagues could allow researchers to design therapeutic ...
Mar 15, 2019
0
0
Yale researchers have discovered several genetic variants that signal the risk of serious suicide attempts and noted some variants have also been linked to major depressive disorder, they report Jan. 17 in the journal Translational ...
Jan 21, 2019
0
66
St. Jude Children's Research Hospital has re-defined the gold standard for diagnostic testing of childhood cancer patients in the precision-medicine era and has implemented the testing for new cancer patients. The findings ...
Oct 12, 2018
0
23
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?
Oct 12, 2018
0
56
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at Sahlgrenska University Hospital, ...
Sep 7, 2018
0
0
Growing threats to public health could be addressed by cutting-edge research that reveals how farm animals contribute to the spread of drug-resistant bacteria, a study suggests.
May 31, 2018
0
2
Affordable, rapid DNA sequencing is causing a revolution in medicine and healthcare globally—and it's happening now, says Thomas Barlow (Barlow Advisory), the author of the landmark Garvan Global Genomics Report, which ...
May 4, 2018
0
8
Before a conclusive link between the SDs and the cardiovascular diseases can be made, further analysis is required on the CAD interval in more patients with coronary artery disease and in the human population, using the TAR ...
Mar 26, 2018
0
2
Physicians are increasingly using genetic testing to unravel mysterious or rare diseases in patients with baffling symptoms. But untangling mystifying symptoms is only half the battle. The next frontier in genomic analysis ...
Sep 12, 2017
0
38
